Signature Estate & Investment Advisors LLC cut its position in UnitedHealth Group Inc. (NYSE:UNH) by 10.8% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 102,517 shares of the healthcare conglomerate’s stock after selling 12,377 shares during the period. UnitedHealth Group accounts for approximately 2.3% of Signature Estate & Investment Advisors LLC’s holdings, making the stock its 12th largest position. Signature Estate & Investment Advisors LLC’s holdings in UnitedHealth Group were worth $14,475,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of UNH. MCF Advisors LLC raised its stake in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares during the last quarter. Parkside Financial Bank & Trust raised its position in UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares in the last quarter. Feltz Wealth PLAN Inc. bought a new position in UnitedHealth Group during the second quarter worth approximately $143,000. Benjamin F. Edwards & Company Inc. raised its position in UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares in the last quarter. Finally, Evanson Asset Management LLC bought a new position in UnitedHealth Group during the second quarter worth approximately $201,000. 85.78% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.20% on Tuesday, reaching $139.44. 594,143 shares of the company traded hands. UnitedHealth Group Inc. has a 52-week low of $107.51 and a 52-week high of $144.48. The stock has a 50 day moving average of $138.69 and a 200 day moving average of $135.65. The stock has a market cap of $132.80 billion, a price-to-earnings ratio of 21.82 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The company earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. On average, analysts expect that UnitedHealth Group Inc. will post $7.92 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.79%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio is 39.12%.
A number of research firms recently commented on UNH. Oppenheimer Holdings Inc. reiterated an “outperform” rating and set a $161.00 price objective (up previously from $145.00) on shares of UnitedHealth Group in a research note on Friday, July 22nd. Barclays PLC raised their price objective on shares of UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a research note on Wednesday, July 20th. Citigroup Inc. raised their price objective on shares of UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research note on Wednesday, July 20th. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective on the stock in a research note on Friday, July 22nd. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective on the stock in a research note on Friday, July 22nd. One investment analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $154.96.
In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.65% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.